Industry / Belgium
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Reimbursed Drug Spending Stays Within Budget
February 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Belgium's efforts to keep drug spending down look as if they are being rewarded, with sales of reimbursed drugs increasing by less than 7% in 2007, within the national health insurance budget for the year. An increased uptake of low-cost medicines medicines has been the main reason for the success, according to pharmaceutical industry association Pharma.be.